The Eletriptan with the cas number 143322-58-1, is also called 13-(((R)-1-Methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)indole; and 1H-Indole, 3-(((2R)-1-methyl-2-pyrrolidinyl)methyl)-5-(2-
(phenylsulfonyl)ethyl)ethyl)-. It belongs to the following product categories such as (1)pharmaceutical material and intermeidates; (2)Chiral Reagents; (3)Intermediates & Fine Chemicals; (4)Pharmaceuticals; (5)APIs

Properties of Eletriptan are: (1)ACD/BCF (pH 5.5): 1 ; (2)ACD/BCF (pH 7.4): 1 ; (3)ACD/KOC (pH 5.5): 1 ; (4)ACD/KOC (pH 7.4): 1.84 ; (5)#H bond acceptors: 4 ; (6)#H bond donors: 1 ; (7)#Freely Rotating Bonds: 6 ; (8)Polar Surface Area: 50.69Ų ; (9)Index of Refraction: 1.633 ; (10) Molar Refractivity: 110.61 cm³ ; (11)Molar Volume: 309.4 cm³ ; (12)Polarizability: 43.85 ×10 ^-24cm³ ; (13)Surface Tension: 53.4 dyne/cm ; (14)Density: 1.235 g/cm³ ; (15)Flash Point: 324.8 °C ; (16)Enthalpy of Vaporization: 91.04 kJ/mol ; (17)Boiling Point: 613.4 °C at 760 mmHg ; (18)Vapour Pressure: 5.52E-15 mmHg at 25°C

The Eletriptan is applicable for acute treatment with migraine headaches with signs or without signs. During clinical study, the most common adverse effects of Eletriptan are as the following, such as fatigue, drowsiness, nausea and dizziness. Eletriptan is forbidden from the one who is allergic to this product. Besides, Eletriptan is also disabled to the one who has severe liver or kidney damage, high blood pressure not to be controlled, coronary heart disease, peripheral vascular diseases, the one who are ictal ischemia of unexpected blood vessel of brain. This product should not used together with ergotamine or ergotamine derivant.

You can still convert the following datas into molecular structure :
1. SMILES: O=S(=O)(c1ccccc1)CCc4ccc2c(c(cn2)C[C@@H]3N(C)CCC3)c4
2. InChI: InChI=1/C22H26N2O2S/c1-24-12-5-6-19(24)15-18-16-23-22-10-9-17(14-21(18)22)11-13-27(25,26)20-7-3-2-4-8-20/h2-4,7-10,14,16,19,23H,5-6,11-13,15H2,1H3/t19-/m1/s1